Home NDC 31722-216 Daptomycin
Product NDC 31722-216
11-digit product format 317220216
Labeler code 31722
Product ID 31722-216_501f9f98-aaa8-e148-e063-6394a90aeb1b
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Daptomycin
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Camber Pharmaceuticals, Inc.
Application ANDA216413
Marketing category ANDA
Marketing start 2022-09-23
Substance DAPTOMYCIN
Active strength 500 mg/10mL
Pharmacologic classes Lipopeptide Antibacterial [EPC], Lipopeptides [CS]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A216413-001 DAPTOMYCIN DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A216413-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A216413-001 DAPTOMYCIN 500MG/VIAL INJECTABLE / INJECTION AP 2022-09-23 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A216413-001 DAPTOMYCIN 500MG/VIAL INJECTABLE / INJECTION AP 2022-09-23 f41ea6bd6efb…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A216413-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-09-23 a50c72e98297…
Observed Orange Book normalized TE history# Additional Listing Data#
Finished product Yes
Brand name base Daptomycin
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength DAPTOMYCIN 500 mg/10mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination NWQ5N31VKK Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 403920 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 31722-216-01 Daptomycin 10 mL in 1 VIAL, SINGLE-DOSE INJECTION, POWDER, LYOPHILIZED, 10 4 31722-216-01 Daptomycin 1 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 1 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 31722-216 DAPTOMYCIN (DAPTOMYCIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CAMBER PHARMACEUTICALS, INC.] 2 Current NDC, Legacy NDC, 2 package rows 20221029_1d29832c-564b-4694-842a-50aeeb823ec8.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 31722-216-01 31722021601 1 VIAL, SINGLE-DOSE in 1 CARTON (31722-216-01) / 10 mL in 1 VIAL, SINGLE-DOSE 2022-09-23 0000-00-00 No No Current